CMS Open Payments · Program Year 2024
Endolumik, Inc.
Endolumik, Inc. reported $1,311,830.16 across General Payments, Research, and Ownership to 20 physicians and teaching hospitals across 29 transactions.
- $1.3M Above-median payer
- All-tracks total
- 29 Below-median volume
- Transactions
- 20 Below-median reach
- Recipients
- #558
- of 1,925 companies
Endolumik, Inc. reported $1,311,830.16 across all CMS Open Payments tracks (General + Research + Ownership) to 20 physicians and teaching hospitals in Program Year 2024 - ranking #558 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $7,830.16, averaging $65.6K per recipient.
How Endolumik, Inc.'s $1.3M all-tracks total breaks down
Endolumik, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
23/100
Total payments
F
22/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer endolumik-inc Endolumik, Inc.
$1.3M · #558/1,925 · 0.0% industry · PY2024
- TOT $1.3M
- RANK #558
- SHARE 0.0%
- TXN 29
- RCP 20
- CAT 4
- GEN $7.8K
- TOP1 26.8%
- PY 2024
Volume peers
Nearest volume peer: Erbe Elektromedizin GmbH ($1.3M)
Endolumik, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Endolumik, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Endolumik, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
"Compensation for Services Other Than Consulting" leads the 4-category general-payment breakdown below at $5.4K (69.0% of General Payments, 10 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Endolumik, Inc. made 4 types of general payments. "Compensation for Services Other Than Consulting" is the largest category at $5.4K, 69.0% of General Payments.
Endolumik, Inc. reports 4 general-payment categories - the top three are Compensation for Services Other Than Consulting (69.0%), Travel and Lodging (21.0%), and Compensation for Faculty or Speaker (Medical Education) (7.1%). The remaining 1 category make up 3.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Endolumik, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $5.4K | 10 | 69.0% |
| Travel and Lodging | $1.6K | 6 | 21.0% |
| Compensation for Faculty or Speaker (Medical Education) | $552.58 | 1 | 7.1% |
| Food and Beverage | $235.50 | 3 | 3.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $7,277.58 (92.9%) of $7,830.16 in this company's General Payments records across 6 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Endolumik, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Darin Minkin
$2,100.00 across 3 reported transactions
- 2
Nova Szoka
$1,877.58 across 9 reported transactions
- 3
Alan Saber
$1,600.00 across 3 reported transactions
- 4
Helmuth Billy
$1,000.00 across 1 reported transactions
- 5
Paul Enochs
$700.00 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Endolumik, Inc.'s spend rank (#558 of 1,925, top 29% by spend) and concentration rank (#755 of 1,838, top 41% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- 60 Degrees Pharmaceuticals : $5.2K total payments, HHI 2026
- iSchemaView, Inc. : $178.4K total payments, HHI 2026
- OraPharma, a division of Bausch Health US, LLC : $539.1K total payments, HHI 2014
- Diality Inc. : $1.5K total payments, HHI 2011
- FUJIFILM Corporation : $77.8K total payments, HHI 2008
- Radformation Inc : $1.7K total payments, HHI 2007
- Endolumik, Inc. (this company) : $7.8K total payments, HHI 2005
- Ecs Opco 1 LLC : $1.6K total payments, HHI 1973
- OrthoFundamentals, LLC : $57.3K total payments, HHI 1972
- VectivBio AG : $30.1K total payments, HHI 1971
- Trice Medical, Inc. : $369.8K total payments, HHI 1959
- Dentsply Ih Ab : $186.8K total payments, HHI 1956
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Endolumik, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Endolumik, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Endolumik, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Smisson-Cartledge Biomedical
Sight Sciences, Inc.
Ironshore Pharmaceuticals Inc.
Sonendo Inc
Spinal Elements, Inc.
Put this to use
Endolumik, Inc. ranks #558 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See where Endolumik, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Endolumik, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.